| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced Epithelial Ovarian Cancer: 1998 Consensus Statements
|
J. S. Berek
|
|
1999
|
10 |
1 |
p. 87-92
6 p.
|
artikel
|
| 2 |
Applying evidence to the individual patient
|
Straus, S.E.
|
|
|
10 |
1 |
p. 29-32
|
artikel
|
| 3 |
Applying evidence to the individual patient
|
S. E. Straus
|
|
1999
|
10 |
1 |
p. 29-32
4 p.
|
artikel
|
| 4 |
Are physicians aware of what patients know about what physicians know?
|
Sabbioni, M.E.E.
|
|
|
10 |
1 |
p. 11-12
|
artikel
|
| 5 |
Are physicians aware of what patients know about what physicians know?
|
M. E. E. Sabbioni
|
|
1999
|
10 |
1 |
p. 11-12
2 p.
|
artikel
|
| 6 |
Awards, appointments
|
|
|
|
10 |
1 |
p. 5
|
artikel
|
| 7 |
Basic Research: How Much do we Know, and What are we Likely to Learn About Ovarian Cancer in the Near Future?
|
T. C. Hamilton
|
|
1999
|
10 |
1 |
p. 69-73
5 p.
|
artikel
|
| 8 |
Bone marrow scintigraphy using Technetium-99m antigranulocyte antibody in malignant lymphomas
|
Krause, T.
|
|
|
10 |
1 |
p. 79-86
|
artikel
|
| 9 |
Bone marrow scintigraphy using Technetium-99m antigranulocyte antibody in malignant lymphomas
|
T. Krause
|
|
1999
|
10 |
1 |
p. 79-85
7 p.
|
artikel
|
| 10 |
Book review
|
Nolé, F.
|
|
|
10 |
1 |
p. 8
|
artikel
|
| 11 |
Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer
|
Dr. Basser, R.L.
|
|
|
10 |
1 |
p. 53-58
|
artikel
|
| 12 |
Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer
|
R. L. Basser
|
|
1999
|
10 |
1 |
p. 53-58
6 p.
|
artikel
|
| 13 |
Chemotherapy for advanced pancreatic cancer: It may no longer be ignored
|
Dr. Cascinu, S.
|
|
|
10 |
1 |
p. 105-110
|
artikel
|
| 14 |
Chemotherapy for advanced pancreatic cancer: It may no longer be ignored
|
S. Cascinu
|
|
1999
|
10 |
1 |
p. 105-109
5 p.
|
artikel
|
| 15 |
Contents of the next issue
|
|
|
|
10 |
1 |
p. vi
|
artikel
|
| 16 |
Copyright
|
|
|
|
10 |
1 |
p. iv
|
artikel
|
| 17 |
Dendritic cells: A novel therapeutic modality
|
Luykx-de-Bakker, S.A.
|
|
|
10 |
1 |
p. 21-28
|
artikel
|
| 18 |
Dendritic cells: A novel therapeutic modality
|
S. A. Luykx-de Bakker
|
|
1999
|
10 |
1 |
p. 21-27
7 p.
|
artikel
|
| 19 |
Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck
|
Schöffski, P.
|
|
|
10 |
1 |
p. 119-122
|
artikel
|
| 20 |
Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck
|
P. Schöffski
|
|
1999
|
10 |
1 |
p. 119-122
4 p.
|
artikel
|
| 21 |
Editorial Board
|
|
|
|
10 |
1 |
p. v
|
artikel
|
| 22 |
First Line Chemotherapy with Carboplatin Plus Paclitaxel in Advanced Ovarian Cancer - a New Standard of Care?
|
A. du Bois
|
|
1999
|
10 |
1 |
p. 35-41
7 p.
|
artikel
|
| 23 |
Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma
|
Lazzarino, M.
|
|
|
10 |
1 |
p. 59-64
|
artikel
|
| 24 |
Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkins lymphoma
|
M. Lazzarino
|
|
1999
|
10 |
1 |
p. 59-64
6 p.
|
artikel
|
| 25 |
Gemcitabine in the Treatment of Ovarian Cancer
|
S. W. Hansen
|
|
1999
|
10 |
1 |
p. 51-53
3 p.
|
artikel
|
| 26 |
H. A. Reber (ed), Pancreatic cancer. Pathogenesis, diagnosis, and treatment
|
F. Nolé
|
|
1999
|
10 |
1 |
p. 8-8
1 p.
|
artikel
|
| 27 |
How Long Should First-line Chemotherapy Continue?
|
K. Bertelsen
|
|
1999
|
10 |
1 |
p. 17-20
4 p.
|
artikel
|
| 28 |
Huge increase in NIH budget
|
|
|
|
10 |
1 |
p. 3-4
|
artikel
|
| 29 |
Instructions for Authors
|
|
|
1999
|
10 |
1 |
p. 127-128
2 p.
|
artikel
|
| 30 |
Instruction to authors
|
|
|
|
10 |
1 |
p. 127-128
|
artikel
|
| 31 |
Intergroup Collaboration in Ovarian Cancer: A Giant Step Forward
|
M. J. Piccart
|
|
1999
|
10 |
1 |
p. 83-86
4 p.
|
artikel
|
| 32 |
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury*
|
Shipp, M.A.
|
|
|
10 |
1 |
p. 13-20
|
artikel
|
| 33 |
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkins lymphomas: Report of the jury
|
M. A. Shipp
|
|
1999
|
10 |
1 |
p. 13-19
7 p.
|
artikel
|
| 34 |
In this issue
|
|
|
|
10 |
1 |
p. vi
|
artikel
|
| 35 |
Intraperitoneal Treatment and Dose-intense Therapy in Ovarian Cancer
|
R. F. Ozols
|
|
1999
|
10 |
1 |
p. 59-64
6 p.
|
artikel
|
| 36 |
Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996
|
Hao, D.
|
|
|
10 |
1 |
p. 65-70
|
artikel
|
| 37 |
Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996
|
D. Hao
|
|
1999
|
10 |
1 |
p. 65-70
6 p.
|
artikel
|
| 38 |
Large increase in support for US cooperative groups
|
|
|
|
10 |
1 |
p. 2
|
artikel
|
| 39 |
Misunderstanding in cancer patients: Why shoot the messenger?
|
Gattellari, M.
|
|
|
10 |
1 |
p. 39-46
|
artikel
|
| 40 |
Misunderstanding in cancer patients: Why shoot the messenger?
|
M. Gattellari
|
|
1999
|
10 |
1 |
p. 39-46
8 p.
|
artikel
|
| 41 |
More on cancer vaccine
|
Roggero, Enrico
|
|
|
10 |
1 |
p. 1-2
|
artikel
|
| 42 |
More on cancer vaccine; Large increase in support for US cooperative groups; Sunshine over ESMO in Athens; Huge increase in NIH budget; Not too much new from the German government; WHO proposes international treaty against tobacco; Oncologist confirmed as FDA Commissioner; Awards, appointments; Perhaps not everyone knows that...
|
|
|
1999
|
10 |
1 |
p. 1-7
7 p.
|
artikel
|
| 43 |
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up
|
Mauriac, L.
|
|
|
10 |
1 |
p. 47-52
|
artikel
|
| 44 |
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up
|
L. Mauriac
|
|
1999
|
10 |
1 |
p. 47-52
6 p.
|
artikel
|
| 45 |
New Non-cytotoxic Approaches to Ovarian Cancer
|
S. B. Kaye
|
|
1999
|
10 |
1 |
p. 65-68
4 p.
|
artikel
|
| 46 |
Not too much new from the German government
|
|
|
|
10 |
1 |
p. 4
|
artikel
|
| 47 |
Oncologist confirmed as FDA Commissioner
|
|
|
|
10 |
1 |
p. 5
|
artikel
|
| 48 |
Oral ipriflavone (7-isopropoxyisoflavone) treatment for elderly patients with resistant acute leukemias
|
Pagano, L.
|
|
|
10 |
1 |
p. 124-125
|
artikel
|
| 49 |
Oral ipriflavone (7-isopropoxy-isoflavone) treatment for elderly patients with resistant acute leukemias
|
L. Pagano
|
|
1999
|
10 |
1 |
p. 124-125
2 p.
|
artikel
|
| 50 |
Ovarian Cancer: Should we be Managing Patients with Good and Bad Prognostic Factors in the Same Manner?
|
E. A. Eisenhauer
|
|
1999
|
10 |
1 |
p. 9-15
7 p.
|
artikel
|
| 51 |
Oxaliplatin in Ovarian Cancer
|
C. Sessa
|
|
1999
|
10 |
1 |
p. 55-57
3 p.
|
artikel
|
| 52 |
Perhaps not everyone knows that…
|
|
|
|
10 |
1 |
p. 5-7
|
artikel
|
| 53 |
Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma
|
Kreis, W.
|
|
|
10 |
1 |
p. 33-38
|
artikel
|
| 54 |
Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma
|
W. Kreis
|
|
1999
|
10 |
1 |
p. 33-38
6 p.
|
artikel
|
| 55 |
Preface
|
Jan P. Neijt
|
|
1999
|
10 |
1 |
p. 1-1
1 p.
|
artikel
|
| 56 |
Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluation
|
Freyer, G.
|
|
|
10 |
1 |
p. 87-96
|
artikel
|
| 57 |
Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluation
|
G. Freyer
|
|
1999
|
10 |
1 |
p. 87-95
9 p.
|
artikel
|
| 58 |
Randomised Trials in Ovarian Cancer: Trial Design Considerations
|
M. F. Brady
|
|
1999
|
10 |
1 |
p. 75-82
8 p.
|
artikel
|
| 59 |
Reduced health-related quality of life among Hodgkin's disease survivors: A comparative study with general population norms
|
Loge, J.H.
|
|
|
10 |
1 |
p. 71-78
|
artikel
|
| 60 |
Reduced health-related quality of life among Hodgkins disease survivors: A comparative study with general population norms
|
J. H. Loge
|
|
1999
|
10 |
1 |
p. 71-77
7 p.
|
artikel
|
| 61 |
Sunshine over ESMO in Athens
|
|
|
|
10 |
1 |
p. 2-3
|
artikel
|
| 62 |
Surgery During Chemotherapy and at Relapse of Ovarian Cancer
|
J. S. Berek
|
|
1999
|
10 |
1 |
p. 3-7
5 p.
|
artikel
|
| 63 |
Table of Contents
|
|
|
|
10 |
1 |
p. iii-iv
|
artikel
|
| 64 |
Telomerase or telomersyn?
|
G¨ll¨, I.H.
|
|
|
10 |
1 |
p. 125-126
|
artikel
|
| 65 |
Telomerase or telomersyn?
|
I. H. Güllü
|
|
1999
|
10 |
1 |
p. 125-125
1 p.
|
artikel
|
| 66 |
The first decade
|
Cavalli, F.
|
|
|
10 |
1 |
p. 9-10
|
artikel
|
| 67 |
The first decade
|
F. Cavalli
|
|
1999
|
10 |
1 |
p. 9-9
1 p.
|
artikel
|
| 68 |
The Gynecologic Oncology Group Experience in Ovarian Cancer
|
W. P. McGuire
|
|
1999
|
10 |
1 |
p. 29-34
6 p.
|
artikel
|
| 69 |
The potential of platinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy
|
Welters, M.J.P.
|
|
|
10 |
1 |
p. 97-104
|
artikel
|
| 70 |
The potential of platinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy
|
M. J. P. Welters
|
|
1999
|
10 |
1 |
p. 97-103
7 p.
|
artikel
|
| 71 |
The Role of Anthracyclines in Epithelial Ovarian Cancer
|
J. B. Vermorken
|
|
1999
|
10 |
1 |
p. 43-50
8 p.
|
artikel
|
| 72 |
This letter was referred to the author, who responds as follows
|
Buesa, J.M.
|
|
|
10 |
1 |
p. 123-124
|
artikel
|
| 73 |
This letter was referred to the author, who responds as follows:
|
J. M. Buesa
|
|
1999
|
10 |
1 |
p. 123-124
2 p.
|
artikel
|
| 74 |
Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse
|
Rummel, M.J.
|
|
|
10 |
1 |
p. 115-118
|
artikel
|
| 75 |
Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse
|
M. J. Rummel
|
|
1999
|
10 |
1 |
p. 115-117
3 p.
|
artikel
|
| 76 |
Treatment of soft-tissue sarcomas: High-dose ifosfamide or combination of ifosfamide and etoposide?
|
Yalçin, S.
|
|
|
10 |
1 |
p. 123
|
artikel
|
| 77 |
Treatment of soft-tissue sarcomas: High-dose ifosfamide or combination of ifosfamide and etoposide?
|
S. Yalçn
|
|
1999
|
10 |
1 |
p. 123-123
1 p.
|
artikel
|
| 78 |
Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis
|
Mimori, K.
|
|
|
10 |
1 |
p. 111-114
|
artikel
|
| 79 |
Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis
|
K. Mimori
|
|
1999
|
10 |
1 |
p. 111-113
3 p.
|
artikel
|
| 80 |
Use of Tumour Markers in Monitoring the Course of Ovarian Cancer
|
G. J. S. Rustin
|
|
1999
|
10 |
1 |
p. 21-27
7 p.
|
artikel
|
| 81 |
WHO proposes international treaty against tobacco
|
|
|
|
10 |
1 |
p. 4-5
|
artikel
|
Tijdschrift beschrijving